The company increased its outlook for 2026 adjusted earnings to $7.30 to $7.50 a share, it said in a statement Wednesday. The 30-cent increase puts the new range above Wall Street estimates.
CVS shares rose as much as 9.8% when markets opened in New York.
WATCH: CVS raised its earnings outlook for the year after profit and revenue in the first quarter exceeded analyst expectations, the latest in a string of positive reports from US health conglomerates. Ike Swetlitz reports. Source: Bloomberg
The company, which includes a retail pharmacy, an insurer and a pharmacy benefits manager, followed every major ...